Skip to content

Clinical trials

Atherosclerosis trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: Greece Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20082
20111
20122
20151
20181
20204
20214
20223
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting7
Recruiting5
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Eli Lilly and Company3
Aristotle University Of Thessaloniki2
AstraZeneca2
CSL Behring2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Cardiovascular Research Society, Greece1
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)1
Hippocration General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis28
Cardiovascular Diseases8
Coronary Artery Disease8
Peripheral Arterial Disease6
Heart Diseases4
Dyslipidemias3
Myocardial Infarction3
Stroke3
Angina, Stable2
Atrial Fibrillation2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.